Xenon Pharmaceuticals Inc.
US ˙ NasdaqGM ˙ CA98420N1050

Introduction

This page provides a comprehensive analysis of the known insider trading history of Gover Justin D.. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Gover Justin D. has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:XENE / Xenon Pharmaceuticals Inc. Director 0
Chief Executive Officer, Director 0
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Gover Justin D.. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases XENE / Xenon Pharmaceuticals Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in XENE / Xenon Pharmaceuticals Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

XENE / Xenon Pharmaceuticals Inc. Insider Trades
Insider Sales XENE / Xenon Pharmaceuticals Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in XENE / Xenon Pharmaceuticals Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

XENE / Xenon Pharmaceuticals Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Gover Justin D. as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2023-08-10 3 XENE Xenon Pharmaceuticals Inc.
No securities are beneficially owned.
0
2021-05-07 2021-05-05 4 GWPH GW PHARMACEUTICALS PLC
Share Options
D - Sale to Issuer -263,184 0 -100.00
2021-05-07 2021-05-05 4 GWPH GW PHARMACEUTICALS PLC
Share Options
D - Sale to Issuer -164,496 0 -100.00
2021-05-07 2021-05-05 4 GWPH GW PHARMACEUTICALS PLC
Share Options
D - Sale to Issuer -479,844 0 -100.00
2021-05-07 2021-05-05 4 GWPH GW PHARMACEUTICALS PLC
Share Options
D - Sale to Issuer -287,904 0 -100.00
2021-05-07 2021-05-05 4 GWPH GW PHARMACEUTICALS PLC
Share Options
D - Sale to Issuer -55,488 0 -100.00
2021-05-07 2021-05-05 4 GWPH GW PHARMACEUTICALS PLC
Share Options
D - Sale to Issuer -12,492 0 -100.00
2021-05-07 2021-05-05 4 GWPH GW PHARMACEUTICALS PLC
Share Options
D - Sale to Issuer -226,752 0 -100.00
2021-05-07 2021-05-05 4 GWPH GW PHARMACEUTICALS PLC
Share Options
D - Sale to Issuer -34,008 0 -100.00
2021-05-07 2021-05-05 4 GWPH GW PHARMACEUTICALS PLC
Share Options
D - Sale to Issuer -22,440 0 -100.00
2021-05-07 2021-05-05 4 GWPH GW PHARMACEUTICALS PLC
Share Options
D - Sale to Issuer -30,936 0 -100.00
2021-05-07 2021-05-05 4 GWPH GW PHARMACEUTICALS PLC
Share Options
D - Sale to Issuer -119,472 0 -100.00
2021-05-07 2021-05-05 4 GWPH GW PHARMACEUTICALS PLC
Share Options
D - Sale to Issuer -147,624 0 -100.00
2021-05-07 2021-05-05 4 GWPH GW PHARMACEUTICALS PLC
Share Options
D - Sale to Issuer -142,344 0 -100.00
2021-05-07 2021-05-05 4 GWPH GW PHARMACEUTICALS PLC
Share Options
D - Sale to Issuer -213,240 0 -100.00
2021-05-07 2021-05-05 4 GWPH GW PHARMACEUTICALS PLC
Share Options
D - Sale to Issuer -75,864 0 -100.00
2021-05-07 2021-05-05 4 GWPH GW PHARMACEUTICALS PLC
Share Options
D - Sale to Issuer -17,508 0 -100.00
2021-05-07 2021-05-05 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
D - Sale to Issuer -1,867,308 0 -100.00
2021-05-07 2021-05-05 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
D - Sale to Issuer -456,048 0 -100.00
2021-05-07 2021-05-05 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
D - Sale to Issuer -222,773 0 -100.00
2021-03-22 2021-03-19 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
G - Gift -276,000 1,867,308 -12.88
2021-03-04 2021-03-02 4 GWPH GW PHARMACEUTICALS PLC
Share Options
A - Award 164,496 164,496
2021-03-04 2021-03-02 4 GWPH GW PHARMACEUTICALS PLC
Share Options
A - Award 263,184 263,184
2021-03-02 2021-03-01 4 GWPH GW PHARMACEUTICALS PLC
Share Options
M - Exercise -17,004 0 -100.00
2021-03-02 2021-03-01 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
F - Taxes -8,412 222,773 -3.64 17.85 -150,154 3,976,498
2021-03-02 2021-03-01 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
M - Exercise 17,004 231,185 7.94 0.00 24 324
2021-03-02 2021-02-26 4 GWPH GW PHARMACEUTICALS PLC
Share Options
M - Exercise -101,436 0 -100.00
2021-03-02 2021-02-26 4 GWPH GW PHARMACEUTICALS PLC
Share Options
M - Exercise -24 0 -100.00
2021-03-02 2021-02-26 4 GWPH GW PHARMACEUTICALS PLC
Share Options
M - Exercise -299,196 0 -100.00
2021-03-02 2021-02-26 4 GWPH GW PHARMACEUTICALS PLC
Share Options
M - Exercise -22,440 0 -100.00
2021-03-02 2021-02-26 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
F - Taxes -49,992 214,181 -18.92 17.90 -894,857 3,833,840
2021-03-02 2021-02-26 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
M - Exercise 101,412 264,173 62.31 0.00 142 370
2021-03-02 2021-02-26 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
F - Taxes -12 162,761 -0.01 17.90 -215 2,913,422
2021-03-02 2021-02-26 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
M - Exercise 24 162,773 0.01 0.00 0 228
2021-03-02 2021-02-26 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
F - Taxes -147,806 162,749 -47.59 17.90 -2,645,727 2,913,207
2021-03-02 2021-02-26 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
M - Exercise 299,196 310,555 2,634.00 0.00 419 435
2021-03-02 2021-02-26 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
F - Taxes -11,086 11,359 -49.39 17.90 -198,439 203,326
2021-03-02 2021-02-26 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
M - Exercise 22,440 22,445 448,800.00 0.00 31 31
2021-02-24 2021-02-22 4 GWPH GW PHARMACEUTICALS PLC
Share Options
A - Award 263,184 263,184
2021-02-24 2021-02-22 4 GWPH GW PHARMACEUTICALS PLC
Share Options
A - Award 164,496 164,496
2021-01-06 2020-12-31 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
G - Gift 456,048 456,048
2021-01-06 2020-12-31 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
G - Gift -456,048 5 -100.00
2020-11-17 2020-11-17 4 GWPH GW PHARMACEUTICALS PLC
Stock Options
M - Exercise -42,708 101,409 -29.63
2020-11-17 2020-11-17 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale X -42,708 456,053 -8.56 10.03 -428,361 4,574,212
2020-11-17 2020-11-17 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
M - Exercise 42,708 498,761 9.36 0.00 56 648
2020-11-17 2020-11-16 4 GWPH GW PHARMACEUTICALS PLC
Stock Options
M - Exercise -22,800 144,117 -13.66
2020-11-17 2020-11-16 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale X -22,800 456,053 -4.76 10.02 -228,456 4,569,651
2020-11-17 2020-11-16 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
M - Exercise 22,800 478,853 5.00 0.00 30 623
2020-11-17 2020-11-13 4 GWPH GW PHARMACEUTICALS PLC
Stock Options
M - Exercise -3,924 10 -99.75
2020-11-17 2020-11-13 4 GWPH GW PHARMACEUTICALS PLC
Stock Options
M - Exercise -39,060 166,917 -18.96
2020-11-17 2020-11-13 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale X -42,984 456,053 -8.61 10.01 -430,270 4,565,091
2020-11-17 2020-11-13 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
M - Exercise 3,924 499,037 0.79 0.00 5 649
2020-11-17 2020-11-13 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
M - Exercise 39,060 495,113 8.56 0.00 51 644
2020-11-12 2020-11-12 4 GWPH GW PHARMACEUTICALS PLC
Stock Options
M - Exercise -27,591 205,977 -11.81
2020-11-12 2020-11-12 4 GWPH GW PHARMACEUTICALS PLC
Stock Options
M - Exercise -13,917 0 -100.00
2020-11-12 2020-11-12 4 GWPH GW PHARMACEUTICALS PLC
Stock Options
M - Exercise -22,800 3,934 -85.28
2020-11-12 2020-11-12 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale X -64,308 456,053 -12.36 10.01 -643,723 4,565,091
2020-11-12 2020-11-12 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
M - Exercise 27,591 520,361 5.60 0.00 36 676
2020-11-12 2020-11-12 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
M - Exercise 13,917 492,770 2.91 0.00 18 641
2020-11-12 2020-11-12 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
M - Exercise 22,800 478,853 5.00 0.00 30 623
2020-11-12 2020-11-09 4 GWPH GW PHARMACEUTICALS PLC
Stock Options
M - Exercise -3,600 13,917 -20.55
2020-11-12 2020-11-09 4 GWPH GW PHARMACEUTICALS PLC
Stock Options
M - Exercise -3,600 13,917 -20.55
2020-11-12 2020-11-09 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale X -7,200 456,053 -1.55 10.00 -72,000 4,560,530
2020-11-12 2020-11-09 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
M - Exercise 3,600 463,253 0.78 0.00 5 602
2020-11-12 2020-11-09 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
M - Exercise 3,600 459,653 0.79 0.00 5 598
2020-06-17 2020-06-15 4 GWPH GW PHARMACEUTICALS PLC
Stock Options
M - Exercise -4,164 0 -100.00
2020-06-17 2020-06-15 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
F - Taxes -2,076 456,053 -0.45 10.23 -21,237 4,665,422
2020-06-17 2020-06-15 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
M - Exercise 4,164 458,129 0.92 0.00 5 596
2020-06-08 2020-06-04 4 GWPH GW PHARMACEUTICALS PLC
Share Options
A - Award 287,904 287,904
2020-06-08 2020-06-04 4 GWPH GW PHARMACEUTICALS PLC
Share Options
A - Award 480 480
2020-03-04 2020-03-02 4 GWPH GW PHARMACEUTICALS PLC
Stock Options
M - Exercise -17,510 7 -99.96
2020-03-04 2020-03-02 4 GWPH GW PHARMACEUTICALS PLC
Stock Options
M - Exercise -30,334 0 -100.00
2020-03-04 2020-03-02 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale -8,400 566,513 -1.46 8.40 -70,560 4,758,709
2020-03-04 2020-03-02 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale -24,456 574,913 -4.08 8.31 -203,229 4,777,527
2020-03-04 2020-03-02 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
M - Exercise 17,510 599,369 3.01 0.00 23 779
2020-03-04 2020-03-02 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
M - Exercise 30,334 581,859 5.50 0.00 39 756
2020-02-28 2020-02-26 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale -876 551,525 -0.16 9.21 -8,068 5,079,545
2020-02-28 2020-02-26 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale -1,644 552,401 -0.30 9.17 -15,075 5,065,517
2020-02-28 2020-02-26 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale -9,480 554,045 -1.68 9.01 -85,415 4,991,945
2020-02-05 2020-02-03 4 GWPH GW PHARMACEUTICALS PLC
Stock Options
M - Exercise -202,224 7 -100.00
2020-02-05 2020-02-03 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale X -19,548 563,525 -3.35 9.71 -189,811 5,471,828
2020-02-05 2020-02-03 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale X -110,964 583,073 -15.99 9.63 -1,068,583 5,614,993
2020-02-05 2020-02-03 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale X -71,712 694,037 -9.36 9.57 -686,284 6,641,934
2020-02-05 2020-02-03 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
M - Exercise 202,224 765,749 35.89 0.00 263 995
2019-12-19 2019-12-17 4 GWPH GW PHARMACEUTICALS PLC
Stock Options
M - Exercise -10,668 11 -99.90
2019-12-19 2019-12-17 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale X -5,340 563,525 -0.94 9.17 -48,968 5,167,524
2019-12-19 2019-12-17 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
M - Exercise 10,668 568,865 1.91 0.00 14 740
2019-06-18 2019-06-14 4 GWPH GW PHARMACEUTICALS PLC
Stock Options
A - Award 55,488 55,488
2019-06-18 2019-06-14 4 GWPH GW PHARMACEUTICALS PLC
Stock Options
A - Award 30,936 30,936
2019-06-18 2019-06-14 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
A - Award 16,656 558,197 3.08 0.00 22 726
2019-05-30 2019-05-28 4 GWPH GW PHARMACEUTICALS PLC
Stock Options
M - Exercise -202,224 202,231 -50.00
2019-05-30 2019-05-28 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale X -6,012 541,541 -1.10 15.49 -93,126 8,388,470
2019-05-30 2019-05-28 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale X -19,284 547,553 -3.40 15.43 -297,552 8,448,743
2019-05-30 2019-05-28 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale X -40,728 566,837 -6.70 15.35 -625,175 8,700,948
2019-05-30 2019-05-28 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale X -56,736 607,565 -8.54 15.25 -865,224 9,265,366
2019-05-30 2019-05-28 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale X -26,784 664,301 -3.88 15.17 -406,313 10,077,446
2019-05-30 2019-05-28 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale X -52,680 691,085 -7.08 15.08 -794,414 10,421,562
2019-05-30 2019-05-28 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
M - Exercise 202,224 743,765 37.34 0.00 263 967
2019-03-19 2019-03-15 4 GWPH GW PHARMACEUTICALS PLC
Stock Options
M - Exercise -30,334 60,668 -33.33
2019-03-19 2019-03-15 4 GWPH GW PHARMACEUTICALS PLC
Stock Options
M - Exercise -17,517 0 -100.00
2019-03-19 2019-03-15 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale X -23,400 541,541 -4.14 14.01 -327,834 7,586,989
2019-03-19 2019-03-15 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
D - Sale to Issuer -19 564,941 0.00 13.88 -264 7,841,381
2019-03-19 2019-03-15 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
M - Exercise 47,851 564,960 9.25 0.00 62 734
2019-03-05 2019-03-01 4 GWPH GW PHARMACEUTICALS PLC
Stock Options
A - Award 17,004 17,004
2019-03-05 2019-03-01 4 GWPH GW PHARMACEUTICALS PLC
Stock Options
A - Award 17,004 17,004
2019-03-05 2019-03-01 4 GWPH GW PHARMACEUTICALS PLC
Stock Options
A - Award 17,004 17,004
2019-03-05 2019-03-01 4 GWPH GW PHARMACEUTICALS PLC
Stock Options
A - Award 17,004 17,004
2019-03-05 2019-03-01 4 GWPH GW PHARMACEUTICALS PLC
Stock Options
A - Award 226,752 226,752
2019-03-05 2019-03-01 4 GWPH GW PHARMACEUTICALS PLC
Stock Options
A - Award 119,472 119,472
2019-02-28 2019-02-26 4 GWPH GW PHARMACEUTICALS PLC
Stock Options
M - Exercise -22,440 0 -100.00
2019-02-28 2019-02-26 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale -96 381,773 -0.03 12.28 -1,179 4,688,172
2019-02-28 2019-02-26 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale -11,016 381,869 -2.80 12.45 -137,149 4,754,269
2019-02-28 2019-02-26 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
M - Exercise 22,440 392,885 6.06 0.00 29 511
2019-02-15 2019-02-13 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale X -22,620 370,445 -5.75 12.50 -282,750 4,630,562
2019-01-04 2019-01-02 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale -1,200 393,065 -0.30 8.52 -10,224 3,348,914
2019-01-04 2019-01-02 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale -14,220 394,265 -3.48 8.43 -119,875 3,323,654
2019-01-04 2019-01-02 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale -1,200 408,485 -0.29 8.25 -9,900 3,370,001
2019-01-04 2019-01-02 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale -3,600 409,685 -0.87 8.14 -29,304 3,334,836
2019-01-04 2019-01-02 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
S - Sale -2,400 413,285 -0.58 7.96 -19,104 3,289,749
2018-12-26 2018-12-20 4 GWPH GW PHARMACEUTICALS PLC
Stock Options
M - Exercise -45,240 0 -100.00
2018-12-26 2018-12-20 4 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
M - Exercise 45,240 415,685 12.21 0.00 59 540
2018-10-01 3 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
2,884,204
2018-10-01 3 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
4,657,073
2018-10-01 3 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
2,884,204
2018-10-01 3 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
4,657,073
2018-10-01 3 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
2,884,204
2018-10-01 3 GWPH GW PHARMACEUTICALS PLC
Ordinary Shares
4,657,073
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)